Boostimmune
Seoul · Founded 2021
About Boostimmune
Boostimmune is a biotech company that is developing antibody-based therapies to address unmet oncology needs by modulating immune systems. The company assembled a team of motivated industry experts with an innovative mindset to continue efforts to overcome challenges in treating human cancers with the mission of developing innovative anti-cancer therapies by enhancing the human immune system.
Company Facts
- Founded: 2021
- Legal name: Boostimmune, Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Last round: Series Unknown (Jan 2023)
- Website: boostimmune.com
Canonical: https://fsome.com/organization/boostimmune-8300377 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.